| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Benzocaine 100 mg/g dental gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine poisoning |
Causative agent (attribute) |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Accidental benzocaine poisoning |
Causative agent (attribute) |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Intentional benzocaine poisoning |
Causative agent (attribute) |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| intoxication par la benzocaïne d'intention indéterminée |
Causative agent (attribute) |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine adverse reaction |
Causative agent (attribute) |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to benzocaine (finding) |
Causative agent (attribute) |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine overdose |
Causative agent (attribute) |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Accidental benzocaine overdose |
Causative agent (attribute) |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Intentional benzocaine overdose |
Causative agent (attribute) |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| surdose de benzocaïne d'intention indéterminée |
Causative agent (attribute) |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine compound 100mg lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 1mg throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 30 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine compound injection solution BPC vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 20% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 200 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 20% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 20% otic drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + trimethobenzamide hydrochlor 2%ww/100mg suppositories |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing benzocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Antipyrine + benzocaine + glycerin 54mg/14mg/1cc solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing benzocaine and trimethobenzamide hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| pyrilamine maleate+benzocaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine+menthol 100mg/3mg compound lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing benzocaine and phenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine and resorcinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine and phenazone and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing benzocaine and phenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing benzocaine and triclosan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Accidental benzocaine poisoning |
Causative agent (attribute) |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Intentional benzocaine poisoning |
Causative agent (attribute) |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine and mepyramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing benzocaine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing benzocaine and dequalinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine and salicylamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing benzocaine and tyrothricin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Benzocaine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing benzocaine in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to benzocaine (finding) |
Causative agent (attribute) |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine + trimethobenzamide hydrochloride 2%ww/100mg rectal suppositories |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzocaine in dental dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine 30 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine 30 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine 100 mg/g dental gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine 100 mg/g dental gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine- and cetylpyridinium-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing benzocaine and dequalinium in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine- and mepyramine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Benzocaine- and tyrothricin-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing benzocaine and chloroxylenol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine- and triclosan-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only benzocaine and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine and mepyramine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only benzocaine and dequalinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only benzocaine and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Benzocaine and phenol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only benzocaine and cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only benzocaine and phenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only benzocaine and resorcinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only benzocaine and salicylamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzocaine (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]